CervoMed Inc. Common Stock
$2.43
-$0.12 (-4.71%)
$2.43Day Range$2.58
Key Statistics
Market Cap
$36.74M
Shares Outstanding
15.1M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jun 18, 1996
Round Lot
100
Locale
US
Trading Data
Day Open
$2.53
Day High
$2.58
Day Low
$2.43
Volume
180.9K
VWAP
$2.47
Prev Close
$2.55
Transactions
--
Acc. Volume
--
About CervoMed Inc. Common Stock
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
PHARMACEUTICAL PREPARATIONSSIC 283415 employees20 PARK PLAZA, BOSTON, MA, 02116(617) 744-4400IPO Jun 18, 1996US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001053691
- Composite FIGI
- BBG000N6JH48
- Share Class FIGI
- BBG001SD4Z42
- Ticker Root
- CRVO
- SIC Code
- 2834
About CervoMed Inc. Common Stock (CRVO) Stock
CervoMed Inc. Common Stock (CRVO) closed the 2026-09-18 session at $2.43, down 4.71% versus the previous close (-0.12). The stock opened at $2.53 and traded between $2.43 and $2.58 during that session. Session trading volume was 181K shares. The volume-weighted average price (VWAP) is $2.47.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
CervoMed Inc. Common Stock has a market capitalization of $36.7 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. CRVO is listed on the XNAS exchange. The company employs approximately 15 people. CervoMed Inc. Common Stock is headquartered in BOSTON, MA. The recorded listing date is 1996-06-18.
On this page you can find market CRVO stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.